For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)

Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.

REXULTI® (brexpiprazole) agitation that may happen with dementia

Alzheimer's Disease Insight Report: Current Therapies, Drug

FDA Approves Rexulti for Agitation Associated With Dementia Due to

REXULTI® (brexpiprazole) Agitation associated with dementia due

Important News for Older Adults: FDA Approves First Drug to Treat

Alzheimer's Agitation Seen to Ease with Schizophrenia Drug

What medications are used to treat Alzheimer's?

New approaches to symptomatic treatments for Alzheimer's disease

Speaking Alzheimer's: A Glossary of Common Terms

Drugs Archives - Alzheimer's & Dementia Weekly

REXULTI® (brexpiprazole) Agitation associated with dementia due

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Leqembi Granted Full FDA Approval to Treat Early Alzheimer's Disease